Objectives Pharmacoeconomics and outcomes research (PEOR) has emerged as a key
decision-making tool to optimize patient care and add value to health care services.
Considering the strategic importance of Asian markets and economic constraints in the
pharmaceutical sector, an understanding of current pricing strategies become vital for
market authorization holders as well as payers. Methods An assessment of health care
policies, pricing systems, and reforms impacting reimbursement and market access …